The role of the speech and language therapist in the management of dysarthria and dysphagia in Parkinson's disease

被引：0

作者：

Benaiges, I. Clemente ^{[1
]}

Farret, C. Avino ^{[1
]}

机构：

[1] Hosp Palamos, Serv Med Fis & Rehabil, SSIBE, Palamos 17230, Girona, Spain

来源：

NEUROLOGIA | 2007年

关键词：

dysphagia; Parkinson; LSVT; hypolkinetic dysarthria; speech pathology;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Parkinson's disease (PD) progressively shows alterations in speech and swallowing that increase in frequency and intensity as the disease evolves. This article is a review of the clinical characteristics of these disorders and of the treatment currently available according to the evidence and grade of recommendation. The LSVT method (Lee Silverman Voice Treatment) with a grade of recommendation B is the only treatment with a relevant short term effectiveness that is maintained for 24 months. It improves intelligibility level of speech in idiopathic PD and also indirectly affects improvement of the organs and muscles involved in swallowing.

引用

页码：30 / 33

页数：4

共 50 条

[41] ROLE OF SPEECH HEARING AND LANGUAGE THERAPIST IN CEREBRAL DYSFUNCTION
SCORY, J
LIEBERMAN, E
HURT, JM
CLINICAL PEDIATRICS, 1966, 5 (06) : 357 - +
[42] New Directions Concerning Therapy of Dysarthria: Kinaesthetically-Controlled Speech in Parkinson's Disease
Thissen, Sara
SPRACHE-STIMME-GEHOR, 2020, 44 (01): : 46 - 48
[43] Working with the transgender voice: The role of the speech and language therapist
Thornton, J.
SEXOLOGIES, 2008, 17 (04) : 271 - 276
[44] Speech Biomarkers for Dysarthria in Parkinson's disease (PD) - Clinical Validation Across two Languages
Troeger, J.
Baykara, E.
Doerr, F.
Rusz, J.
Orozco-Arroyave, J. R.
MOVEMENT DISORDERS, 2024, 39 : S574 - S574
[45] Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
Herd, Clare P.
Tomlinson, Claire L.
Deane, Katherine H. O.
Brady, Marian C.
Smith, Christina H.
Sackley, Catherine M.
Clarke, Carl E.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (08):
[46] SPEECH BIOMARKERS FOR DYSARTHRIA IN PARKINSON'S DISEASE - CLINICAL VALIDATION ACROSS SPANISH AND CZECH LANGUAGES
Baykara, E.
Doerr, F.
Rusz, J.
Orozco-Arroyave, J. R.
Troeger, J.
PARKINSONISM & RELATED DISORDERS, 2024, 122
[47] SPEECH-LANGUAGE PATHOLOGISTS' PRACTICE PATTERNS IN THE MANAGEMENT OF COGNITIVE IMPAIRMENT IN PARKINSON′S DISEASE
Neal, Vanessa
Musson, Nan
INNOVATION IN AGING, 2023, 7 : 815 - 815
[48] Guidelines for Speech-Language Therapy in Parkinson's Disease
Kalf, J. G.
de Swart, B. J. M.
Bloem, B. R.
Munneke, M.
MOVEMENT DISORDERS, 2010, 25 : S711 - S711
[49] Speech, voice and language in Parkinson's disease: changes and interventions
Miller, Nick
NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (03) : 279 - 289
[50] Guidelines for speech-language therapy in Parkinson's disease
Kalf, J. G.
De Swart, B-. J.
Bloem, B. R.
Munneke, M.
MOVEMENT DISORDERS, 2008, 23 (01) : S328 - S329

← 1 2 3 4 5 →